Zosano Pharma Corp is under investigation concerning potential Securities Laws violations. The investigation was announced for investors in NASDAQ:ZSAN shares in connection certain financial statements made by the specialty pharmaceutical company.
Investors who purchased shares of Zosano Pharma Corp (NASDAQ:ZSAN), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.
The investigation by a law firm focuses on focuses on whether Zosano Pharma Corp and its officers violated securities laws by issuing misleading information to investors. More specifically, the investigation will focus on whether the Company’s filings with the SEC concerning its January 2015 Initial Public Offering (“IPO”) was misleading.
Zosano Pharma Corporation is a clinical-stage specialty pharmaceutical company that has developed a transdermal microneedle patch system to deliver its formulations of existing drugs through the skin for the treatment of a range of indications. Zosano Pharma Corp went public in January 2015 and shares of Zosano Pharma Corp (NASDAQ:ZSAN) grew to as high as $11.67 per share in March 2015. Since then shares of Zosano Pharma Corp (NASDAQ:ZSAN) declined to as low as $1.95 per share on January 22, 2016.
Shares of Zosano Pharma Corp (NASDAQ:ZSAN) declined from over $11.00 per share in March 2015 to as low as $1.03 per share on June 27, 2016.
Those who purchased NASDAQ:ZSAN shares have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com